柳芳 趙宇 馬莉

[摘要]目的:探索改良型富血小板纖維蛋白(advance platetel-rich fribin,A-PRF)與普通型富血小板纖維蛋白(platetel-rich fribin,PRF)在脂肪移植中的應用效果,進而為臨床應用提供指導。方法:將18只實驗兔隨機分成三組,實驗組(A-PRF組):取兔背部脂肪組織,將2ml A-PRF+1ml顆粒脂肪移植到兔耳分離好的區域;陽性對照組(PRF組):兔耳移植區移入2ml PRF+1ml顆粒脂肪;陰性對照組(NS組):兔耳移植區移入2ml生理鹽水+1ml顆粒脂肪。分別于4周、8周、12周取材進行大體觀察、稱重、HE染色與免疫染色來比較三組間脂肪成活差異。結果:各時間點,A-PRF組的脂肪存活率及新生毛細血管密度明顯優于其他兩組,PRF組結果優于NS組,且三組間比較差異有統計學意義(P<0.05)。結論:A-PRF在增加脂肪細胞成活率、減輕炎癥反應及促進毛細血管新生方面優于普通型PRF,這為A-PRF的臨床使用提供參考。
[關鍵詞]A-PRF;PRF;顆粒脂肪移植;脂肪細胞成活率;VEGF;細胞因子
[中圖分類號]R622 ? ?[文獻標志碼]A ? ?[文章編號]1008-6455(2019)11-0082-04
Abstract: Objective ?To explore the application of advanced platelet-rich fibrin (A-PRF) and common platelet-rich fibrin (PRF) in fat transplantation in rabbit. Provide guidance for clinical applications. Methods ?Eighteen experimental rabbits were divided into three groups randdomly. The experimental group(A-PRF group): adipose tissue was taken, and 2ml A-PRF+1ml granule fat was transplanted into the isolated area of rabbit ears. The positive control group(PRF group): 2ml PRF+1ml granule fat was transferred into the transplantation area. The negative control group(NS group): 2ml physiological saline +1ml granular fat was transplanted. Gross observation, weighing, HE staining and immunostaining were performed at 4 weeks, 8 weeks, and 12 weeks to compare the survival of fat between the three groups. Results ?At each observation time, the fat survival rate and neonatal capillary density of the A-PRF group were significantly better than the other two groups. The positive control group was superior to the negative control group, and the difference was statistically significant (P<0.05). Conclusion ?A-PRF is superior to common PRF in increasing the survival rate of adipocytes, reducing inflammation and promoting capillary angiogenesis, which provides a reference for the use of A-PRF in clinic.
Key words: A-PRF; PRF; granular fat transplantation; adipocyte survival rate; VEGF; cytokines
自體顆粒脂肪移植是整形學科常規項目,常用于軟組織缺損修復,原因如下:①自身脂肪移植避免了移植后的免疫排斥,組織相容性好;②脂肪來源廣泛,供區提供脂肪的同時可局部塑形;③移植后的脂肪細胞可部分存活,有效地保持了受區的體積。然而脂肪移植后伴隨而來的壞死、液化、鈣化、囊腫形成等限制了其臨床應用。臨床上通過各種方法來提升移植脂肪的存活率,如脂肪干細胞與基質血管成分(stromal vascular fraction,SVF)聯合脂肪細胞移植、各種生長因子及后來的富血小板血漿(platelet-rich plasma,PRP)[1]與富血小板纖維蛋白(platetel-rich fribin,PRF)[2]、抗氧化劑添加、促進血管生成藥物使用、獲取過程減少脂肪細胞的損傷、注射方法的改進等。……